Welcome to the
EVER Pharma Webinar
Platform.
We are happy to have you here!
New horizons improving gold standard therapy in acute stroke - Case discussions
Thrombolysis is the gold standard therapy in acute stroke but has considerable limitations – a short treatment window and many exclusion criteria and also many weaknesses like an elevated bleeding risk. The presenters will discuss which role Cerebrolysin can potentially play to improve the safety of thrombolysis and recanalization therapies and will hypothesize based on their own data and experiences how it may support better longterm outcome. Join the case discussions and register now! Duration: 45 minutes Languages: Webinar will be held in English language incl. subtitles if requested and Russian simultaneous translation will be offered.
Our Webinars
#stroke
New horizons improving gold standard therapy in acute stroke - Case discussions
#neurocognitive disorders
Treating cognitive decline after critical illnesses - A call to action
#tbi
Neurorecovery - When evidence from the bench meets results at the bedside
#stroke
The future of chronic stroke patient treatment - Interactive case discussions
On Demand
#stroke
Get with the guidelines in post-stroke motor recovery - Expert panel discussion
#tbi
Evidence-based neurorecovery after stroke and TBI
#stroke
The renaissance of neuroprotection in times of recanalization therapies
#tbi
Innovative strategies to advance severe TBI treatment
#stroke
The relevance of neurorehabilitation in acute and chronic stroke
#tbi
Acute and longterm neurorecovery after TBI
#stroke